Log in to save to my catalogue

Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy...

Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3fa5fe57556c47aaba1efad9b84cc23b

Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?

About this item

Full title

Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?

Publisher

England: BioMed Central

Journal title

BMC medicine, 2017-04, Vol.15 (1), p.82-82, Article 82

Language

English

Formats

Publication information

Publisher

England: BioMed Central

Subjects

Subjects and topics

More information

Scope and Contents

Contents

After publication of the original article [1], it came to the publisher’s attention that the text contained several minor typos. Upon investigation, it transpired that there had been technical issues affecting the copyediting process before the article entered the production stage, resulting in the presence of minor errors, without influence on con...

Alternative Titles

Full title

Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3fa5fe57556c47aaba1efad9b84cc23b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3fa5fe57556c47aaba1efad9b84cc23b

Other Identifiers

ISSN

1741-7015

E-ISSN

1741-7015

DOI

10.1186/s12916-017-0857-x

How to access this item